First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews.

已取消 10 由帝企鹅发布于 2023/11/3 10:44:20

DOI:10.1097/CAD.0000000000001408
作者：WuRongrong, LiuShinan, LvGuoli, DengChaowen, WangRuolan, ZhangShenglin, ZhuDongyi, WangLe, LeiYouming, LuoZhuang
文献类型：其他 (专利、报告等)
补充材料：只需要正文
文献链接：https://doi.org/10.1097/CAD.0000000000001408

Wolters Kluwer Ovid

Abstract：Anaplastic lymphoma kinase (ALK) fusion was found in 3-7% of all patients with nonsmall cell lung cancer. The efficacy of ALK-tyrosine kinase inhibitor (ALK-TKI) in EML4-ALK has been extensi

应助信息

2023-11-03

Book学术机器人

2023/11/3 10:44:46 未找到该文献，机器人已退出，请等待人工下载

2023/11/3 10:44:20 Book学术AI机器人收到请求，开始寻找文献

2023/11/3 10:44:20 已向机器人发送请求

2023-11-03

帝企鹅发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureEnabling giant thermopower by heterostructure engineering of hydrated vanadium pentoxide for zinc ion thermal charging cells